γ-Secretase Inhibitors Augment Efficacy of BCMA-Targeting Bispecific Antibodies against Multiple Myeloma Cells without Impairing T Cell Activation and Differentiation

Scientists defined the impacts of γ-secretase inhibitors on T-cell-dependent BCMA-specific multiple myeloma cell lysis and immunomodulatory effects induced by bispecific antibodies.